Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

<p>This research programme investigated the expression of prolyl hydroxylase (PHD) proteins in rodent tissues. The importance of PHD enzymes lies in their ability to render oxygen sensitivity to Hypoxia inducible factor (HIF), the principal mediator of intracellular oxygen homeostasis. The fir...

Descripció completa

Dades bibliogràfiques
Autor principal:	Wijeyekoon, JB
Altres autors:	Pugh, C
Format:	Thesis
Idioma:	English
Publicat:	2013
Matèries:	Medical Sciences Clinical laboratory sciences

Ítems similars

Regulation of HIF: prolyl hydroxylases.
per: Stolze, I, et al.
Publicat: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
per: Chowdhury, R, et al.
Publicat: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
per: Rasheduzzaman Chowdhury, et al.
Publicat: (2016-08-01)

Tolerance in renal transplantation: is mixed chimerism the missing link?
per: Janes, S, et al.
Publicat: (2009)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
per: McNeill, L, et al.
Publicat: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
per: Tuckerman, JR, et al.
Publicat: (2004)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
per: Mole, D, et al.
Publicat: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
per: Schlemminger, I, et al.
Publicat: (2003)

Studies on HIF hydroxylases
per: Webb, J
Publicat: (2008)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
per: Holt-Martyn, JP, et al.
Publicat: (2019)

Cortical dynamics subserving visual apparent motion
per: Ahmed, B, et al.
Publicat: (2008)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
per: Cockman, M, et al.
Publicat: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
per: Matthew E Cockman, et al.
Publicat: (2019-09-01)

Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners
per: Hongyan Deng, et al.
Publicat: (2024-06-01)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
per: Chan, M, et al.
Publicat: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
per: Yeh, TL, et al.
Publicat: (2017)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
per: Maria Savyuk, et al.
Publicat: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
per: Andrey A. Poloznikov, et al.
Publicat: (2021-01-01)

Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
per: Holt-Martyn, J
Publicat: (2018)

The role of CCL25 and CCR9 in intestinal inflammation
per: Wendt, E, et al.
Publicat: (2013)

Adaptive changes of influenza virus A/H5N1 neuraminidase in vitro and in vivo
per: Le Nguyen, T
Publicat: (2014)

Angiogenesis in human lung tumours
per: Ferguson, ML
Publicat: (2008)

Editorial commentary: Understanding BCG is the key to improving it
per: McShane, H
Publicat: (2014)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
per: Hlela, C
Publicat: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
per: Flashman, E, et al.
Publicat: (2010)

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury
per: Zhao-Ying Ding, et al.
Publicat: (2022-03-01)

Probing the molecular basis of melanopsin induced light sensitivity
per: Vachtsevanos, AN
Publicat: (2012)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
per: Chowdhury, R, et al.
Publicat: (2013)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
per: Lippl, K
Publicat: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
per: Masson, N, et al.
Publicat: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
per: Takahiro Kambara, et al.
Publicat: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
per: Kiichi Hirota
Publicat: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
per: Kilian B. Kennel, et al.
Publicat: (2022-11-01)

HR23B, a biomarker for HDAC inhibitors
per: Khan, OA
Publicat: (2013)

Risk factors for haemorrhage in patients with haematological malignancies
per: Estcourt, LJ
Publicat: (2014)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
per: Willam, C, et al.
Publicat: (2006)

Mechanistic studies on human prolyl hydroxylase domain 2
per: Fiorini, G
Publicat: (2024)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
per: Figg, WD, et al.
Publicat: (2021)

Role of prolyl hydroxylase domain proteins in bone metabolism
per: David Wolf, et al.
Publicat: (2022-03-01)

Transcription regulation of Nrp1 during endothelial cell differentiation
per: Zhao, Z
Publicat: (2014)